Peng Li1, Qigen Fang2, Jinxing Qi3, Ruihua Luo4, Changfu Sun5. 1. Resident, Department of Head Neck and Thyroid Surgery, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, Henan, China. 2. Resident, Department of Head Neck and Thyroid Surgery, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: qigenfang@126.com. 3. Department Head, Department of Head Neck and Thyroid Surgery, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, Henan, China. 4. Professor, Department of Head Neck and Thyroid Surgery, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, Henan, China. 5. Department Head, Department of Oral Maxillofacial Surgery, School of Stomatology, China Medical University, Shenyang, China.
Abstract
PURPOSE: This article reports on the incidence of donor-site complications and identifies predictive factors for early and late donor-site complications. MATERIALS AND METHODS: From January 2007 through December 2012, 45 patients underwent free fibula flap reconstruction and their medical records were reviewed. They were asked to complete a questionnaire on the operated leg and they were evaluated for ankle stability and ambulatory status. RESULTS: One patient (2.2%) developed a complication owing to a hematoma, but no other patients had any complications. During the risk factor analysis, no domain was found to be statistically associated with early morbidity; late dysfunction was noted in 20 patients (57.1%), and of these cases, at least 2 symptoms were found in 10 patients (50%). The most common complication was numbness followed by toe contracture and abnormal ambulatory movement. During the risk analysis, the following domains affected late donor-site morbidity: harvested fibula length, operation time, and follow-up time. Furthermore, in cases with complications, patients with the osteocutaneous fibula flap complained more than patients with the osseous flap (P = .07). CONCLUSION: Early donor-site morbidity was uncommon, but late morbidity occurred frequently. Harvested fibula length, operation time, and follow-up time were statistically linked to postoperative function.
PURPOSE: This article reports on the incidence of donor-site complications and identifies predictive factors for early and late donor-site complications. MATERIALS AND METHODS: From January 2007 through December 2012, 45 patients underwent free fibula flap reconstruction and their medical records were reviewed. They were asked to complete a questionnaire on the operated leg and they were evaluated for ankle stability and ambulatory status. RESULTS: One patient (2.2%) developed a complication owing to a hematoma, but no other patients had any complications. During the risk factor analysis, no domain was found to be statistically associated with early morbidity; late dysfunction was noted in 20 patients (57.1%), and of these cases, at least 2 symptoms were found in 10 patients (50%). The most common complication was numbness followed by toe contracture and abnormal ambulatory movement. During the risk analysis, the following domains affected late donor-site morbidity: harvested fibula length, operation time, and follow-up time. Furthermore, in cases with complications, patients with the osteocutaneous fibula flap complained more than patients with the osseous flap (P = .07). CONCLUSION: Early donor-site morbidity was uncommon, but late morbidity occurred frequently. Harvested fibula length, operation time, and follow-up time were statistically linked to postoperative function.
Authors: Atanas Todorov; Matthias Kreutz; Alexander Haumer; Celeste Scotti; Andrea Barbero; Paul E Bourgine; Arnaud Scherberich; Claude Jaquiery; Ivan Martin Journal: Stem Cells Transl Med Date: 2016-07-26 Impact factor: 6.940